Autologous Bone Marrow Transplantation - Blog Science Connections

520 Etoposide and Cisplatin for Lung Cancer
impetus to continue to explore the upper dose limit of etoposide. A
confirmation of these encouraging results may be indicated through a phase
11 trial employing the final etoposide dose established in this phase I study, and
perhaps using multiple courses of treatment in sequence with autologous
marrow transplants.
ACKNOWLEDGMENTS
This work was supported, in part, by grants from Biospecific Technologies,
Inc., and Bristol-Myers Company.
The authors thank Joyce Neading, A.R.T., for data collection and typing
of the manuscript, and Robert Fox, R.N., for technical support.
REFERENCES
1. O'Dwyer PJ, Leyland-Jones B, Alonso MT, Marsoni S, Wittes RE. N Engl J Med 1985;312:692.
2. Vogelzang NJ, Raghavan D, Kennedy BJ. Am J Med 1982;72:136.
3. Radice PA, Bunn PA, Ihde DC. Cancer Treat Rep 1979:68:1231.
4. Creaven PJ, Newman SJ, Selawry OS, Cohen MH, Primack A. Cancer Chemother Rep
1974:58:901.
5. Frei E III, Canellos GP. Am J Med 1980;69:585.
6. Brindley CO, Salvin LG, Potee KG, et al. J Chronic Dis 1964:17:19.
7. Frei E III, Spurr CL, Brindley CO, Selawry O, Holland JF, Rail DP, Wasserman LR, Hoogstraten
B, Schnider Bl, Mclntyre OR. Clin Pharmacol Ther 1965:6:160.
8. Samson MK, Rivkin SE, Jones SE, Costanzi JJ, LoBuglio AF, Stephens RL, Gehan EA,
CummingsGD. Cancer 1984:53:1029.
9. Ansfield F, Klotz J, Nealon T, et al. Cancer 1977:39:34.
10. Cornbleet MA, McElwain TJ, Kumar PJ, Filshie J, Selby P, Carter RL, Hedley DW, Clark ML,
Millar JL. Br J Cancer 1983;48:329.
11. Maraninchi D, Pico JL, Hartmann O, Gastaut JA, Kamioner D, Hayat M, Mascret B,
Beaujean F, Sebahoun G, Novakovitch G, et al. Cancer Treat Rep 1986;70:445.
12. GoldinA. Cancer Res 1969;29:2285.
13. Schabel FM. In Cancer Chemotherapy: Fundamental Concepts and Recent Advances.
Yearbook Medical Publishers, Chicago, 1975:323.
14. WolffSN,FerMF,McKayCM,HandeKR,HainsworthJD, Greco FA. JClinOncol 1983;1:701.
15. Postmus PE, Mulder NH, Sleijfer DT, Meinesz AF, Vriesendorp R, de Vries EG. Cancer Treat
Rep 1984:68:1471.
16. van Echo DA, Wiernik PH, Aisner J. Cancer Clin Trials 1980:3:325.
17. Chard RL Jr, Krivit W, Bleyer WA, Hammond D. Cancer Treat Rep 1979;63:1755.
18. Schabel FM Jr, Trader MW, Laster WR Jr, Corbett TH, Griswold DP Jr. Cancer Treat Rep
1979:63:1459.
19. Tinsley R, Comis R, DiFino S, et al. Proceedings of the American Association of Clinical
Oncology 1983;2:198.
20. Dombernowsky P, Nissen Nl. Eur J Cancer Clin Oncol 1976:12:181.
21. Burchenal JH, Kalaher K, Dew K, Lokys L. Biochimie 1981;60:961.
22. Evans WK, Osoba D, Feld R, Shepherd FA, Bazos MJ, DeBoer G. J Clin Oncol 1985;3:65.
23. Arnold AM. Cancer Chemother Pharmacol 1979;3:71.
24. Sierocki JS, Hilaris BS, Hopfan S, Golbey RB, Wittes RE. Cancer Treat Rep 1979:63:1593.
25. Evans WK, Shepherd FA, Feld R, Osoba D, Dang P, DeBoer G. J Clin Oncol 1985:3:1471.
26. Longeval E, KlasterskyJ. Cancer 1982:50:2751.